<DOC>
	<DOCNO>NCT00430937</DOCNO>
	<brief_summary>This study evaluate efficacy safety daptomycin compare vancomycin teicoplanin treatment complicate skin soft tissue infection</brief_summary>
	<brief_title>Efficacy Safety Daptomycin Versus Vancomycin Teicoplanin Treatment Complicated Skin Soft Tissue Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Teicoplanin</mesh_term>
	<criteria>Inclusion criterion : Subjects diagnosis cSSTI Infection know suspect ( base Gram 's stain ) due , least partially , Grampositive bacteria . Hospitalised subject clinical evidence least one following : I infect ulcer , major abscess . deep extensive cellulitis , postsurgical / posttraumatic wound infection Presence least two follow : drainage and/or discharge infection site , redness , swell and/or harden skin , heat and/or localise warmth , pain and/or tenderness touch , presence pu . Exclusion criterion : cSSTIs follow category : Infected burn , Severely impaired arterial blood supply ( likelihood amputation infect anatomical site likely ) , Decubitus ulcer , Infected diabetic foot ulcer associate osteomyelitis , Infected human animal bite , superficial infection abscess anatomic site , rectal area , risk anaerobic Gramnegative pathogen involvement high ( e.g . perirectal abscess ) , Necrotising fasciitis gangrene , cSSTI expect require 14 day intravenous antimicrobial therapy , Skin and/or skin structure infection treat surgery alone , Infections associate permanent prosthetic device remove within 2 day study randomisation Subjects document bacteraemia Baseline shock hypotension Concomitant clinically suspect confirmed site infection disorder study entry may interfere evaluation protocol Treatment vancomycin teicoplanin within past 48 hour , unless administer le 24 hour . Subjects admit hospital condition associate rhabdomyolysis infection due organism know prior study entry resistant daptomycin , vancomycin teicoplanin . Previously diagnosed disease immune function . Human Immunodeficiency Virus ( HIV ) infect subject without Acquired Immune Deficiency Syndrome ( AIDS ) may enrol . Subjects receive oral steroid receive immunosuppressant drug organ transplant . Absence purulent material initial culture Gram 's stain . Subjects cellulitis may enrol absence purulent material , provide infection Grampositive organism suspect . Subjects receive 48 hour systemic antibiotic topical antibiotic infection site activity Grampositive pathogen , unless clinical evidence treatment failure OR document resistance identify Grampositive pathogen previous antibiotic therapy . cSSTI suspect documented due exclusively Gramnegative anaerobic organism base epidemiology direct examination Gramstained specimen . Subjects diagnose pneumonia severe renal impairment hepatic disease Previous history hearing loss . Other protocol define inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Complicated Skin Soft Tissue Infections . Daptomycin , Vancomycin , Teicoplanin</keyword>
	<keyword>Complicated skin soft tissue infection</keyword>
</DOC>